Improving access to healthcare in low- and middle-income countries (LMICs) is a global issue. On 8 February 2024, Swiss TPH will bring together experts and key players from the pharmaceutical industry, academia and product development partnerships to assess current strategies and progress and to foster synergies between partners for more effective product development, licensing and implementation. Join them for this multidisciplinary networking event organised in collaboration with Healthcare Dialogues.
Access to drugs, diagnostics and vaccines
|Health equity and access to diagnostics in LMICs
Stefan Seliger, Head of Global Access & Policy, Roche Diagnostics
|Manufacturing and Supply of Vaccines in LMICs
Pierre Morgon, CEO & Founder, MRGN Advisors
|Improving Access for NTDs Drugs in LMICs
Sabine Specht, Head of Filarial Disease, DNDi